United States eterinary Vaccines Market Research Report Forecast 2017-2021

Chapter 1 eterinary Vaccines Market Overview

1.1 Product Overview and Scope of eterinary Vaccines

1.2 eterinary Vaccines Market Segmentation by Type

1.2.1 United States Production Market Share of eterinary Vaccines by Type in 2015

1.2.1 Live Vaccine

1.2.2 DNA Vaccine

1.2.3 Inactivated Vaccines

1.3 eterinary Vaccines Market Segmentation by Application

1.3.1 eterinary Vaccines Consumption Market Share by Application in 2015

1.3.2 Livestock

1.3.3 Poultry

1.3.4 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of eterinary Vaccines (2011-2021)

Chapter 2 United States Economic Impact on eterinary Vaccines Industry

2.1 United States Macroeconomic Analysis

2.2 United States Macroeconomic Environment Development Trend

Chapter 3 United States eterinary Vaccines Market Competition by Manufacturers

3.1 United States eterinary Vaccines Production and Share by Manufacturers (2015 and 2016)

3.2 United States eterinary Vaccines Revenue and Share by Manufacturers (2015 and 2016)

3.3 United States eterinary Vaccines Average Price by Manufacturers (2015 and 2016)

3.4 Manufacturers eterinary Vaccines Manufacturing Base Distribution, Production Area and Product Type

3.5 eterinary Vaccines Market Competitive Situation and Trends

3.5.1 eterinary Vaccines Market Concentration Rate

3.5.2 eterinary Vaccines Market Share of Top 3 and Top 5 Manufacturers

3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 United States eterinary Vaccines Production, Revenue (Value), Price Trend by Type

4.1 United States eterinary Vaccines Production and Market Share by Type (2012-2017)

4.2 United States eterinary Vaccines Revenue and Market Share by Type (2012-2017)

4.3 United States eterinary Vaccines Price by Type (2012-2017)

4.4 United States eterinary Vaccines Production Growth by Type (2012-2017)

Chapter 5 United States eterinary Vaccines Market Analysis by Application

5.1 United States eterinary Vaccines Consumption and Market Share by Application (2012-2017)

5.2 United States eterinary Vaccines Consumption Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

5.3.1 Potential Applications

5.3.2 Emerging Markets/Countries

Chapter 6 United States eterinary Vaccines Manufacturers Analysis

6.1 GE Healthcare

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Product Type, Application and Specification

6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Business Overview

6.2 Bayer Healthcare

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Product Type, Application and Specification

6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Business Overview

6.3 Boehringer Ingelheim

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Product Type, Application and Specification

6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Business Overview

6.4 Ceva Animal Health

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Product Type, Application and Specification

6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Business Overview

6.5 Elanco Animal Health (Eli Lilly)

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Product Type, Application and Specification

6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Business Overview

6.6 Heska Corporation

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Product Type, Application and Specification

6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Business Overview

6.7 Merck Animal Healthcare

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Product Type, Application and Specification

6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Business Overview

6.8 Merial Inc. (SANOFI)

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Product Type, Application and Specification

6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Business Overview

6.9 Virbac

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Product Type, Application and Specification

6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Business Overview

…

Chapter 7 eterinary Vaccines Manufacturing Cost Analysis

7.1 eterinary Vaccines Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of eterinary Vaccines

Chapter 8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 eterinary Vaccines Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015

8.4 Downstream Buyers

Chapter 9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

Chapter 10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

Chapter 11 United States eterinary Vaccines Market Forecast (2017-2021)

11.1 United States eterinary Vaccines Production, Revenue Forecast (2017-2021)

11.2 United States eterinary Vaccines Production, Consumption Forecast by Regions (2017-2021)

11.3 United States eterinary Vaccines Production Forecast by Type (2017-2021)

11.4 United States eterinary Vaccines Consumption Forecast by Application (2017-2021)

11.5 eterinary Vaccines Price Forecast (2017-2021)

Chapter 12 Appendix

Table Classification of eterinary Vaccines

Figure United States Sales Market Share of eterinary Vaccines by Type in 2015

Table Application of eterinary Vaccines

Figure United States Sales Market Share of eterinary Vaccines by Application in 2015

Figure United States eterinary Vaccines Sales and Growth Rate (2011-2021)

Figure United States eterinary Vaccines Revenue and Growth Rate (2011-2021)

Table United States eterinary Vaccines Sales of Key Manufacturers (2015 and 2016)

Table United States eterinary Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 eterinary Vaccines Sales Share by Manufacturers

Figure 2016 eterinary Vaccines Sales Share by Manufacturers

Table United States eterinary Vaccines Revenue by Manufacturers (2015 and 2016)

Table United States eterinary Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States eterinary Vaccines Revenue Share by Manufacturers

Table 2016 United States eterinary Vaccines Revenue Share by Manufacturers

Table United States Market eterinary Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market eterinary Vaccines Average Price of Key Manufacturers in 2015

Figure eterinary Vaccines Market Share of Top 3 Manufacturers

Figure eterinary Vaccines Market Share of Top 5 Manufacturers

Table United States eterinary Vaccines Sales by Type (2012-2017)

Table United States eterinary Vaccines Sales Share by Type (2012-2017)

Figure United States eterinary Vaccines Sales Market Share by Type in 2015

Table United States eterinary Vaccines Revenue and Market Share by Type (2012-2017)

Table United States eterinary Vaccines Revenue Share by Type (2012-2017)

Figure Revenue Market Share of eterinary Vaccines by Type (2012-2017)

Table United States eterinary Vaccines Price by Type (2012-2017)

Figure United States eterinary Vaccines Sales Growth Rate by Type (2012-2017)

Table United States eterinary Vaccines Sales by Application (2012-2017)

Table United States eterinary Vaccines Sales Market Share by Application (2012-2017)

Figure United States eterinary Vaccines Sales Market Share by Application in 2015

Table United States eterinary Vaccines Sales Growth Rate by Application (2012-2017)

Figure United States eterinary Vaccines Sales Growth Rate by Application (2012-2017)

Table GE Healthcare Basic Information, Manufacturing Base, Production Area and Its Competitors

Table GE Healthcare eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table GE Healthcare eterinary Vaccines Market Share (2012-2017)

Table Bayer Healthcare Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Bayer Healthcare eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Bayer Healthcare eterinary Vaccines Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Boehringer Ingelheim eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim eterinary Vaccines Market Share (2012-2017)

Table Ceva Animal Health Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Ceva Animal Health eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Ceva Animal Health eterinary Vaccines Market Share (2012-2017)

Table Elanco Animal Health (Eli Lilly) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Market Share (2012-2017)

Table Heska Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Heska Corporation eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Heska Corporation eterinary Vaccines Market Share (2012-2017)

Table Merck Animal Healthcare Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Merck Animal Healthcare eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Merck Animal Healthcare eterinary Vaccines Market Share (2012-2017)

Table Merial Inc. (SANOFI) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Merial Inc. (SANOFI) eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Merial Inc. (SANOFI) eterinary Vaccines Market Share (2012-2017)

Table Virbac Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Virbac eterinary Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Virbac eterinary Vaccines Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of eterinary Vaccines

Figure Manufacturing Process Analysis of eterinary Vaccines

Figure eterinary Vaccines Industrial Chain Analysis

Table Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015

Table Major Buyers of eterinary Vaccines

Table Distributors/Traders List

Figure United States eterinary Vaccines Production and Growth Rate Forecast (2017-2021)

Figure United States eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)

Table United States eterinary Vaccines Production Forecast by Type (2017-2021)

Table United States eterinary Vaccines Consumption Forecast by Application (2017-2021)